93
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Angiogenesis Biomarkers in Ischemic Stroke Patients

ORCID Icon, , , , , , , & show all
Pages 4893-4900 | Published online: 22 Sep 2021

References

  • Sacco RL, Kasner SE, Broderick JP, et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(7):2064–2089. doi:10.1161/STR.0b013e318296aeca
  • Nilupul Perera M, Ma HK, Arakawa S, et al. Inflammation following stroke. J Clin Neurosci. 2006;13(1):1–8. doi:10.1016/j.jocn.2005.07.005
  • De Chiara G, Marcocci ME, Sgarbanti R, et al. Infectious agents and neurodegeneration. Mol Neurobiol. 2012;46(3):614–638.
  • Ramesh G, MacLean AG, Philipp MT. Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain. Mediators Inflamm. 2013;2013:480739. doi:10.1155/2013/480739
  • Gendelman HE. Neural immunity: friend or foe? J Neurovirol. 2002;8(6):474–479. doi:10.1080/13550280290168631
  • Vidale S, Consoli A, Arnaboldi M, Consoli D. Postischemic inflammation in acute stroke. J Clin Neurol. 2017;13(1):1–9. doi:10.3988/jcn.2017.13.1.1
  • Marlier Q, Verteneuil S, Vandenbosch R, Malgrange B. Mechanisms and functional significance of stroke-induced neurogenesis. Front Neurosci. 2015;9:458. doi:10.3389/fnins.2015.00458
  • Ruan L, Wang B, ZhuGe Q, Jin K. Coupling of neurogenesis and angiogenesis after ischemic stroke. Brain Res. 2015;1623:166–173. doi:10.1016/j.brainres.2015.02.042
  • Chen J, Cui X, Zacharek A, Chopp M. Increasing Ang1/Tie2 expression by simvastatin treatment induces vascular stabilization and neuroblast migration after stroke. J Cell Mol Med. 2009;13(7):1348–1357. doi:10.1111/j.1582-4934.2008.00380.x
  • Chen J, Zhang C, Jiang H, et al. Atorvastatin induction of VEGF and BDNF promotes brain plasticity after stroke in mice. J Cerebral Blood Flow Metabol. 2005;25(2):281–290. doi:10.1038/sj.jcbfm.9600034
  • Ding J, Cheng Y, Gao S, Chen J. Effects of nerve growth factor and Noggin-modified bone marrow stromal cells on stroke in rats. J Neurosci Res. 2011;89(2):222–230. doi:10.1002/jnr.22535
  • Seto SW, Chang D, Jenkins A, Bensoussan A, Kiat H. Angiogenesis in ischemic stroke and angiogenic effects of Chinese herbal medicine. J Clin Med. 2016;5(6):56. doi:10.3390/jcm5060056
  • Casscells W. Growth factor therapies for vascular injury and ischemia. Circulation. 1995;91(11):2699–2702. doi:10.1161/01.CIR.91.11.2699
  • Zacchigna S, Lambrechts D, Carmeliet P. Neurovascular signalling defects in neurodegeneration. Nat Rev Neurosci. 2008;9(3):169–181. doi:10.1038/nrn2336
  • Talwar T, Srivastava MV. Role of vascular endothelial growth factor and other growth factors in post-stroke recovery. Ann Indian Acad Neurol. 2014;17(1):1–6. doi:10.4103/0972-2327.128519
  • Suwanwela N, Koroshetz WJ. Acute ischemic stroke: overview of recent therapeutic developments. Annu Rev Med. 2007;58(1):89–106. doi:10.1146/annurev.med.58.070605.115306
  • Conley BA, Smith JD, Guerrero-Esteo M, Bernabeu C, Vary CPH. Endoglin, a TGF-beta receptor-associated protein, is expressed by smooth muscle cells in human atherosclerotic plaques. Atherosclerosis. 2000;153(2):323–335. doi:10.1016/S0021-9150(00)00422-6
  • Akagi K, Ikeda Y, Sumiyoshi Y, et al. Estimation of angiogenesis with anti-CD105 immunostaining in the process of colorectal cancer development. Surgery. 2002;131(1):S109–S113. doi:10.1067/msy.2002.119361
  • Dziewulska D, Rafalowska J. Role of endoglin and transforming growth factor-beta in progressive white matter damage after an ischemic stroke. Neuropathology. 2006;26(4):298–306. doi:10.1111/j.1440-1789.2006.00700.x
  • Sánchez-Elsner T, Botella LM, Velasco B, Langa C, Bernabéu C. Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-β pathways. J Biol Chem. 2002;277(46):43799–43808. doi:10.1074/jbc.M207160200
  • England TJ, Sprigg N, Alasheev AM, et al. Granulocyte-Colony Stimulating Factor (G-CSF) for stroke: an individual patient data meta-analysis. Sci Rep. 2016;6:36567. doi:10.1038/srep36567
  • Salonia R, Empey PE, Poloyac SM. Endothelin-1 is increased in cerebrospinal fluid and associated with unfavorable outcomes in children after severe traumatic brain injury. J Neurotrauma. 2010;27(10):1819–1825. doi:10.1089/neu.2010.1402
  • Cheng YW, Li WJ, Dou XJ, et al. Role of endothelin‑1 and its receptors in cerebral vasospasm following subarachnoid hemorrhage. Mol Med Rep. 2018;18(6):5229–5236.
  • Yeung PKK, Shen J, Chung SSM, Chung SK. Targeted over-expression of endothelin-1 in astrocytes leads to more severe brain damage and vasospasm after subarachnoid hemorrhage. BMC Neurosci. 2013;14(1):131. doi:10.1186/1471-2202-14-131
  • Lo AC, Chen AY, Hung VK, et al. Endothelin-1 overexpression leads to further water accumulation and brain edema after middle cerebral artery occlusion via aquaporin 4 expression in astrocytic end-feet. J Cerebral Blood Flow Metabol. 2005;25(8):998–1011. doi:10.1038/sj.jcbfm.9600108
  • GBD 2016 Lifetime Risk of Stroke Collaborators. Global, regional, and country-specific lifetime risks of stroke, 1990 and 2016. N Engl J Med. 2018;379(25):2429–2437. doi:10.1056/NEJMoa1804492
  • Arenillas JF, Sobrino T, Castillo J, Dávalos A. The role of angiogenesis in damage and recovery from ischemic stroke. Curr Treat Options Cardiovasc Med. 2007;9(3):205–212. doi:10.1007/s11936-007-0014-5
  • Zhang ZG, Zhang L, Jiang Q, Chopp M. Bone marrow-derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral ischemia in the adult mouse. Circ Res. 2002;90(3):284–288. doi:10.1161/hh0302.104460
  • Ghani U, Shuaib A, Salam A, et al. Endothelial progenitor cells during cerebrovascular disease. Stroke. 2005;36(1):151–153. doi:10.1161/01.STR.0000149944.15406.16
  • Lopez MF, Sarracino DA, Prakash A, et al. Discrimination of ischemic and hemorrhagic strokes using a multiplexed, mass spectrometry-based assay for serum apolipoproteins coupled to multi-marker ROC algorithm. Proteomics Clin Appl. 2012;6(3–4):190–200. doi:10.1002/prca.201100041
  • Gurnik S, Devraj K, Macas J, et al. Angiopoietin-2-induced blood-brain barrier compromise and increased stroke size are rescued by VE-PTP-dependent restoration of Tie2 signaling. Acta Neuropathol. 2016;131(5):753–773. doi:10.1007/s00401-016-1551-3
  • Augustin HG, Young Koh G, Thurston G, Alitalo K. Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system. Nat Rev Mol Cell Biol. 2009;10(3):165–177. doi:10.1038/nrm2639
  • Eklund L, Saharinen P. Angiopoietin signaling in the vasculature. Exp Cell Res. 2013;319(9):1271–1280. doi:10.1016/j.yexcr.2013.03.011
  • Reiss Y, Scholz A, Plate KH. The angiopoietin—tie system: common signaling pathways for angiogenesis, cancer, and inflammation. In: Schmidt MHH, Liebner S, editors. Endothelial Signaling in Development and Disease. New York: Springer New York; 2015:313–328.
  • Sato TN, Tozawa Y, Deutsch U, et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature. 1995;376(6535):70–74. doi:10.1038/376070a0
  • Maisonpierre PC, Suri C, Jones PF, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science. 1997;277(5322):55–60. doi:10.1126/science.277.5322.55
  • Zhu W, Ma L, Zhang R, Su H. The roles of endoglin gene in cerebrovascular diseases. Neuroimmunol Neuroinflam. 2017;4:199–210. doi:10.20517/2347-8659.2017.18
  • Sapira V, Cojocaru I, Lilios G, Grigorian M, Cojocaru M. Study of endothelin-1 in acute ischemic stroke. Roman J Internal Med. 2010;48:329–332.
  • Abumiya T, Lucero J, Heo JH, et al. Activated microvessels express vascular endothelial growth factor and integrin αvβ3 during focal cerebral ischemia. J Cerebral Blood Flow Metabol. 1999;19(9):1038–1050. doi:10.1097/00004647-199909000-00012
  • Zhang ZG, Zhang L, Tsang W, et al. Correlation of VEGF and angiopoietin expression with disruption of blood–brain barrier and angiogenesis after focal cerebral ischemia. J Cerebral Blood Flow Metabol. 2002;22(4):379–392. doi:10.1097/00004647-200204000-00002
  • Kovács Z, Ikezaki K, Samoto K, Inamura T, Fukui M. VEGF and flt. Expression time kinetics in rat brain infarct. Stroke. 1996;27(10):1865–72; discussion 72–3. doi:10.1161/01.STR.27.10.1865
  • Mu D, Jiang X, Sheldon RA, et al. Regulation of hypoxia-inducible factor 1α and induction of vascular endothelial growth factor in a rat neonatal stroke model. Neurobiol Dis. 2003;14(3):524–534. doi:10.1016/j.nbd.2003.08.020
  • Chen HH, Chien CH, Liu HM. Correlation between angiogenesis and basic fibroblast growth factor expression in experimental brain infarct. Stroke. 1994;25(8):1651–1657. doi:10.1161/01.STR.25.8.1651
  • Liu HM. Neovasculature and blood-brain barrier in ischemic brain infarct. Acta Neuropathol. 1988;75(4):422–426. doi:10.1007/BF00687796
  • Krupinski J, Kaluza J, Kumar P, Kumar S, Wang JM. Role of angiogenesis in patients with cerebral ischemic stroke. Stroke. 1994;25(9):1794–1798. doi:10.1161/01.STR.25.9.1794
  • Zhang ZG, Zhang L, Jiang Q, et al. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest. 2000;106(7):829–838. doi:10.1172/JCI9369
  • Sun Y, Jin K, Xie L, et al. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest. 2003;111(12):1843–1851. doi:10.1172/JCI200317977
  • Yu S-C, Kuo C-L, Huang C-S, et al. Endogenous granulocyte colony-stimulating factor: a biomarker in acute ischemic stroke. Biomarkers. 2012;17(4):319–324. doi:10.3109/1354750X.2012.668712